The company is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry
Alkem Laboratories, India's fifth largest pharma firm by domestic sales, is planning to hit the market with an issue of around Rs 1,500 crore
This year, 18 firms that have so far launched IPOs, raising Rs 11,000 cr, making it the best in four years in terms of fund raising
The shares are proposed to be listed on BSE and NSE
Plans to raise issue with investment bankers
Successful listing comes within a week of IndiGo's trading debut
The IPO would be of up to 24,694,500 shares of Mahanagar Gas Limited, as per the Draft Red Herring Prospectus (DRHP) filed with Sebi
An IPO for the Indian unit has been delayed by a long-running tax dispute with the government and fierce competition in the market
Investors who applied for the Coffee Day IPO were disappointed because it fell about 18% on the listing day
Coffee Day disappoints; all eyes on IndiGo, SH Kelkar
Alkem, a producer of generic drugs, had filed a draft prospectus with India's capital markets regulator in August for an IPO of up to 12.85 mn equity shares
The book-building closed last week, having attracted orders worth six times the number of available shares
The book-building closed last week, having attracted orders worth six times the number of available shares
Fund raising through IPOs in 2015 touches Rs 11,000 cr, nine times that of 2014
PNB owns 51% stake in PNB Housing, while Carlyle Group owns the rest
70% of bids from foreign investors; share offering lapped up six times; retail quota under-subscribed
The new norms will come into effect from December 1
HNI category has got 1.14 times subscribed and the retail quota was subscribed 42%
IndiGo, Coffee Day offers point to change in approach towards pricing, as compared to 2 years earlier; hand-holding of retail investors not deemed necessary